The possibility of using citrulline as a new biochemical marker to evaluate the state of kidney under cardiovascular pathologies

  • O. Kuchmenko SI “National Scientific Center “Strazhesko Institute of Cardiology” NAMS of Ukraine, Gogol Nizhyn State University, Nizhyn, Ukraine, National University of Kyiv-Mohyla Academy
  • L. Mkhytaryan SI “National Scientific Center “Strazhesko Institute of Cardiology” NAMS of Ukraine, Gogol Nizhyn State University, Nizhyn, Ukraine
  • I. Ievstratova SI “National Scientific Center “Strazhesko Institute of Cardiology” NAMS of Ukraine
  • O. Matova SI “National Scientific Center “Strazhesko Institute of Cardiology” NAMS of Ukraine
  • V. Vasylchenko National University of Kyiv-Mohyla Academy
Keywords: citrulline, creatinine, GFR, arterial hypertension, chronic heart failure

Abstract

The aim of our work was to study the level of citrulline in serum as a biochemical marker of the functional state of the kidneys in patients with cardiovascular pathologies.

Methods. The study included 134 patients aged 41-68 years, of which 40 patients with stage II arterial hypertension (AG-II) and 62 patients with chronic heart failure (AG in combination with chronic ischemic heart disease) in the IIa and IIb stages. The control group included 32 practically healthy persons of the corresponding age. Along with standard diagnostic methods, the content of citrulline in serum was determined. Statistical analysis was performed using SPSS 10.0 for Windows.

Results. There is a direct relationship between the increase in the content of citrulline and the severity of changes in the parameters of the functional state of the kidneys in patients with AG-II and CHF. At the same time, the fact that the content of citrulline in serum is much higher compared to the control values in patients with normal values of GFR, creatinine and microalbuminuria. As the increase in the content of citrulline directly correlates with the degree of deterioration of the functional state of the kidneys, and the kidneys are the only organ that regulates and controls the exchange of citrulline, the increase in its level in serum can be primarily associated with changes in kidney function in the examined patients.

Conclusions. The content of citrulline in serum can be used as an additional marker for the presence of functional renal impairment in patients with cardiovascular and other diseases of the internal organs, especially in the early stages of development, as well as to assess the efficacy and safety of the use of drugs. This indicator needs further study involving more patients with different pathologies of the cardiovascular system and simultaneous monitoring of the functional status of the kidneys by standardized methods.

Downloads

Download data is not yet available.

References

Bahri S, Zerrouk N, Aussel C, Moinard C, Crenn P, Curis E, Chaumeil JC, Cynober L, Sfar S Citrulline: from metabolism to therapeutic use. Nutrition. 2013;29(3):479-484.      doi: 10.1016/j.nut.2012.07.002.

Moinard C, Cynober L Citrulline: a new player in the control of nitrogen homeostasis. J. Nutr. 2007; 137:1621S–1625S. doi: 10.1093/jn/137.6.1621S.

Cynober L, de Bandt JP, Moinard C Leucine and citrulline: two major regulators of protein turnover. World Rev. Nutr. Diet. 2013;105:97-105. doi:  10.1159/000341278.

Cynober L Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients? Crit. Care. 2013;17(2):122. doi: 10.1186/cc12534.

Kaore SN, Amane HS, Kaore NM Citrulline: pharmacological perspectives and its role as an emerging biomarker in future. Fundam. Clin. Pharmacol. 2013;27(1):35-50.  doi: 10.1111/j.1472-8206.2012.01059.

Lin IC, Hsu CN, Lo MH, Chien SJ, Tain YL Low urinary citrulline/arginine ratio associated with blood pressure abnormalities and arterial stiffness in childhood chronic kidney disease. J. Am. Soc. Hypertens. 2016;10(2):115–123. doi: 10.1016/j.jash.2015.11.008.

Reddy YS, Kiranmayi VS, Bitla AR, Krishna GS, Rao PV, Sinakumar V Nitric oxide status in patients with chronic kidney disease. Indian J. Nephrol. 2015;25(5):287–291. doi: 10.4103/0971-4065.147376.

de Meirelles LR, Resende Ade C, Matsuura C, Salgado A, Pereira NR, Cascarelli PG, Mendes-Ribeiro AC, Brunini TM Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure. Clin. Exp. Pharmacol. Physiol. 2011;38(10):705–710. doi: 10.1111/j.1440-1681.2011.05580.  

Rath M, Muller I, Kropf P, Closs EI, Munder M Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Frontiers in Immunology. 2014;5:532. doi: 10.3389/fimmu.2014.00532.

Snell FD, Snell ST Colorimetric method of analysis. New York: Van Nostard; 2013:153–155.

KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplement. 2013;3:1-150.

Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2013;41(1):1-12. doi: 10.1053/ajkd.2003.50007.

Smirnov AV, Dobronravov VA, Kayukov IG The problem of chronic kidney disease in current medicine. Arterialnaya hipertensiya. 2006;12(3):185–193 [in Russian].

Rayner HC, Pisoni RL, Bommer J Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol. Dial. Transplant. 2004;19:108-120. doi: 10.1093/ndt/gfg483

Berl T, Henrich W Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin. J. Am. Soc. Nephrol. 2006;1:8-18. doi: 10.2215/CJN.00730805.

Published
2018-12-26
How to Cite
Kuchmenko, O., Mkhytaryan, L., Ievstratova, I., Matova, O., & Vasylchenko, V. (2018). The possibility of using citrulline as a new biochemical marker to evaluate the state of kidney under cardiovascular pathologies. Ukrainian Journal of Nephrology and Dialysis, (4(60), 35-39. https://doi.org/10.31450/ukrjnd.4(60).2018.05